Evaluation of chargeable amino acids effects on intractable epileptic patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201112178436N1

Enrollment

Registered

2012-03-03

Start date

2012-02-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy. Epilepsy

Interventions

Intervention 1: Group 3 (10patients) recived Arginine (three times of daily needs) for two weeks before breakfast. Intervention 2: Intractable epileptic patients have studdied. Group 1(10 patients) re

Treatment - Drugs

Group 3 (10patients) recived Arginine (three times of daily needs) for two weeks before breakfast.

Intractable epileptic patients have studdied. Group 1(10 patients) recieved Glutamic acid (Three times of daily needs) for two weeks every morninig before breakfast .

Group 2 (10 patients) reicived Lyzine (three times of daily needs) for two weeks befor break fast

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterion: all epileptic patients that do not have any responce to antiepileptic drug. Exclusion criteria: pregnant women; lactating women; history of psychiatric diseas; viral infection and other seriuos diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Epileptic attacks. Timepoint: Two weeks. Method of measurement: Number of attacks.	—

Secondary

Measure	Time frame
The number of seizure attacks. Timepoint: For three weeks ( one before and one in first week an other in second week). Method of measurement: The number of seizure attacks reported by patients or family.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholam Reza Sepehri

Research office

gsepehri@yahoo.com+98 21 15780

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026